Witzeman Michael D's Form 4 filing
Chemed Corp (CHE) · filed Nov 4, 2022
- Accession no.
- 0001209191-22-055758
- Filed
- Nov 4, 2022
- Trade date
- Nov 3-4, 2022
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 3 non-derivative transactions and 1 derivative transaction. Open-market sales total $627.4K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Witzeman Michael DCIK 0001699624 | Officer (vice president and controller) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 3, 2022 | capital stock | SSaleDisposed | −1,300 | $482.62 | −$627,406 | 1,186 | Direct | |
| Nov 4, 2022 | capital stock | MOption exerciseAcquired | +6,900 | $306.70 | +$2,116,230 | 8,086 | Direct | |
| Nov 4, 2022 | capital stock | FTax withholdingDisposed | −5,450 | $479.27 | −$2,612,021.5 | 2,636 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 4, 2022 | capital stock | MOption exerciseDisposed | −6,900 | $306.70 | −$2,116,230 | 32,293 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.